Clinical Results of Proton-Beam Therapy for Locoregionally Advanced Esophageal Cancer

[1]  T. Sakae,et al.  Comparisons of Dose-Volume Histograms for Proton-Beam versus 3-D Conformal X-Ray Therapy in Patients with Stage I Non-Small Cell Lung Cancer , 2009, Strahlentherapie und Onkologie.

[2]  Stephen Breen,et al.  Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  P. Georg,et al.  Assessment of Improved Organ at Risk Sparing for Advanced Cervix Carcinoma Utilizing Precision Radiotherapy Techniques , 2008, Strahlentherapie und Onkologie.

[4]  J. Ajani,et al.  Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Radhe Mohan,et al.  Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer. , 2008, International journal of radiation oncology, biology, physics.

[6]  Kyung-Ja Cho,et al.  Treatment outcome and recursive partitioning analysis-based prognostic factors in patients with esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[7]  D. Sugarbaker,et al.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. Ohara,et al.  Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis. , 2007, International journal of radiation oncology, biology, physics.

[9]  T. Teshima,et al.  Results of the 1999 2001 Japanese patterns of care study for patients receiving definitive radiation therapy without surgery for esophageal cancer. , 2007, Japanese journal of clinical oncology.

[10]  Val Gebski,et al.  Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. , 2007, The Lancet. Oncology.

[11]  V. Gebski,et al.  Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. , 2005, The Lancet. Oncology.

[12]  G. Jiang,et al.  Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. , 2005, International journal of radiation oncology, biology, physics.

[13]  K. Kagei,et al.  Proton Beam Therapy for Hepatocellular Carcinoma: A Retrospective Review of 162 Patients , 2005, Clinical Cancer Research.

[14]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  A. Venturi,et al.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis , 2004, Gut.

[16]  Narikazu Boku,et al.  Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[18]  Jian Z. Wang,et al.  Optimizing external-beam radiotherapy and brachytherapy for localized prostate cancer using equivalent uniform dose model , 2002 .

[19]  Xiaomao Guo,et al.  Comparison between continuous accelerated hyperfractionated and late-course accelerated hyperfractionated radiotherapy for esophageal carcinoma. , 2002, International journal of radiation oncology, biology, physics.

[20]  R. Ginsberg,et al.  INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Y. Nakanishi,et al.  Clinicopathologic characteristics and survival of patients with clinical Stage I squamous cell carcinomas of the thoracic esophagus treated with three-field lymph node dissection. , 2001, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[22]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Cooper,et al.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. , 1999, JAMA.

[24]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[25]  D. Carter.  TNM Classification of Malignant Tumors , 1998 .

[26]  J. Siebers,et al.  Proton dosimetry intercomparison. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  K. Sugimachi,et al.  Lugol‐combined Endoscopie Detection of Minute Malignant Lesions of the Thoracic Esophagus , 1988, Annals of surgery.

[28]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[29]  K. Kagei,et al.  Clinical results of proton beam therapy for cancer of the esophagus. , 2005, International journal of radiation oncology, biology, physics.

[30]  S. Law.  Chemoradiotherapy - panacea for esophageal cancer? Commentary for 'Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01)' , 1999 .

[31]  H. Tsujii,et al.  Clinical results of fractionated proton therapy. , 1993, International journal of radiation oncology, biology, physics.

[32]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.

[33]  D.,et al.  Regression Models and Life-Tables , 2022 .